|
|
Halozyme Therapeutics, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPROŽ (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis |
|
|
return to message board, top of board |
